| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4273397 | The Journal of Sexual Medicine | 2006 | 11 Pages |
Abstract
This preliminary evaluation suggests the potential for bremelanotide to positively affect desire and arousal in women with female sexual arousal disorder and indicates that bremelanotide is a promising candidate for further evaluation in an atâhome study. Diamond LE, Earle DC, Heiman JR, Rosen RC, Perelman MA, and Harning R. An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PTâ141), a melanocortin receptor agonist. J Sex Med 2006;3:628-638.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Lisa E. PhD, Dennis C. BS, Julia R. PhD, Raymond C. PhD, Michael. A. PhD, Ronald PhD,